Prevalencia de los trastornos hipertensivos del embarazo en mujeres embarazadas controladas en Assbasalud E.S.E, Manizales (Colombia), 2006 a 2008

Gil, Maida Lizzeth Agudeli; Ramos, Lina María Agudelo; Castrillón, José Jaime Castaño; Giraldo, Jorge Alonso Beltrán; Vélez, Andrés Felipe Hoyos; Bucheli, Ana María Lara; Salazar, Anderson Molina; Meneses, Andrea Carolina Piragua; Piedrahíta, Andrés Ramos

doi:10.30554/archmed.10.2.1293.2010

Cited by 6 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Preeclampsia is one of the main obstetric diseases, 1–5 it affects 2–3% of pregnant women, and it responsible for approximately 10% of patient's deaths all over the world 1,5–8 . In Colombia, preeclampsia is the first cause of maternal morbidity–mortality, with an incidence between 3–14% and 25% of mortality associated with hypertensive disorders 3–5,9,10 …”

Section: Introductionmentioning

confidence: 99%

“…1,[5][6][7][8] In Colombia, preeclampsia is the first cause of maternal morbidity-mortality, with an incidence between 3-14% and 25% of mortality associated with hypertensive disorders. [3][4][5]9,10 An important outcome associated is fetal growth restriction (FGR). 4,[11][12][13] Due to the important repercussion of these diseases, many methods have been designed to determine their risk.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high‐risk population

Infante

Uriel

Porras-Ramírez

et al. 2020

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim: To compare the sensitivity and specificity of screening for preeclampsia and FGR including maternal characteristics, mean arterial blood pressure and uterine artery pulsatility index and the combined screening, which adds biochemical markers, such as placental growth factor (PlGF) and pregnancy-associated plasma protein-A (PAPP-A), in a sample of high risk population for hypertensive disorders. Methods: This is a prospective study with 527 singleton pregnancies at 11-14 weeks of gestation. Maternal characteristics, biochemical and biophysical markers were studied to determine the development of preeclampsia and FGR by using receiver operating characteristic curves. Results: For preeclampsia, screening, including sociodemographic data plus biophysical markers, had a sensitivity and specificity of 70.3% (CI% 64.3-75.2) and 93.8% (CI% 90.9-96.8), respectively. Combined screening, which includes sociodemographic data, biophysical (mean blood pressure and uterine artery pulsatility index) and biochemical markers (PlGF and PAPP-A), increased sensitivity and specificity up to 85.5% (CI% 80.2-90.3) and 96.3% (CI% 91.4-98.9), respectively. For FGR, sociodemographic data plus biophysical markers had a sensitivity and specificity of 57.8% (CI% 50.1-63.4) and 80.1% (CI% 74.3-85.9), respectively. Combined screening increased sensitivity and specificity up to 67.2% (CI% 52.1-71.3) and 82.7% (CI% 75.2-90.1), respectively. Conclusion: Combined screening for preeclampsia and FGR at 11 to 14 weeks of gestation, which includes maternal characteristics, mean blood pressure, uterine artery pulsatility index, PAPP-A and PlGF, has higher sensitivity and specificity than other screening options. Therefore, considering all these variables during screening is recommended for a superior opportunity of identifying pregnant women in risk for preeclampsia and FGR, especially in a high-risk population.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high‐risk population

Infante

Uriel

Porras-Ramírez

et al. 2020

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

First trimester placental growth factor in maternal blood and placenta related disorders

Infante

Uriel

Franco

et al. 2021

The Journal of Maternal-Fetal & Neonatal Medicine

View full text Add to dashboard Cite

Preeclampsia leve y severa: estudio de casos y controles en el Hospital de Chiquinquirá 2012-2014

Jaramillo

Vásquez²,

Medina

2017

Rev. Colomb. Enferm.

View full text Add to dashboard Cite

<p>La preeclampsia es una de las principales causas de morbimortalidad materna y fetal en Colombia y un problema de salud pública importante en la zona de influencia del Hospital Regional de Chiquinquirá (Boyacá, Colombia), pero no se ha cuantificado su magnitud ni los factores de riesgo. El objetivo de este estudio analítico fue determinar los factores de riesgo en casos de preeclampsia leve y severa en gestantes atendidas en dicha institución entre 2012 y 2014 para ayudar al diagnóstico temprano, la vigilancia y la prevención de complicaciones y secuelas. Se realizó un estudio de casos y controles retrospectivo. Se evaluaron 356 historias clínicas, 122 casos y 234 controles. Se realizaron análisis descriptivos, bivariados apoyados por OR con IC 95%, comparación entre grupos a partir de pruebas T-student y U de Mann-Whitney y análisis estratificado por edades. Los resultados: procedencia, raza, régimen y educación no presentaron asociaciones significativas (p >0,05); antecedentes de preeclampsia, hipertensión arterial, cesárea en embarazos anteriores, período intergenésico mayor a 10 años e índice de masa corporal al final del embarazo mayor a 35, son factores de riesgo (p <0,05). Se concluye que el estrato socioeconómico 2 y la raza mestiza son factores protectores; los análisis estratificados no mostraron confusión por la variable edad; no existe distorsión de la relación entre las variables antecedentes de preeclampsia, hipertensión, cesáreas anteriores y preeclampsia. Las acciones de intervención para factores de riesgo en la población de estudio deben dirigirse a los estratos más bajos y población más vulnerable.</p>

show abstract

Prevalencia de los trastornos hipertensivos del embarazo en mujeres embarazadas controladas en Assbasalud E.S.E, Manizales (Colombia), 2006 a 2008

Cited by 6 publications

References 20 publications

Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high‐risk population

Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high‐risk population

First trimester placental growth factor in maternal blood and placenta related disorders

Preeclampsia leve y severa: estudio de casos y controles en el Hospital de Chiquinquirá 2012-2014

Contact Info

Product

Resources

About